75:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
•  High respiratory rate with decreased oxygen satura:@0.076190:0.084931:0.475923:0.084931:0.475923:0.069149:0.076190:0.069149:0.009162:0.004188:0.006804:0.010326:0.003024:0.010175:0.009223:0.005065:0.004551:0.009827:0.005866:0.010311:0.003024:0.004551:0.010326:0.005125:0.009903:0.004551:0.008104:0.005050:0.004551:0.010326:0.005125:0.009827:0.005050:0.012564:0.003024:0.005125:0.009223:0.005065:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.005050:0.009903:0.007257:0.008104:0.010175:0.009827:0.009223:0.005050:0.005866:0.010326:0.005125:0.009192:0.004551:0.010326
-:@0.475923:0.084931:0.480942:0.084931:0.480942:0.069149:0.475923:0.069149:0.005020
tion:@0.096344:0.099098:0.123619:0.099098:0.123619:0.083315:0.096344:0.083315:0.005125:0.003024:0.009903:0.009223
•  Development  of  new  physical  signs,  such  as  pedal :@0.076190:0.113264:0.485115:0.113264:0.485115:0.097481:0.076190:0.097481:0.009162:0.004188:0.006804:0.011249:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.014182:0.009827:0.009223:0.005125:0.004188:0.002283:0.009903:0.004747:0.004188:0.002283:0.009223:0.009827:0.012564:0.004188:0.002283:0.010311:0.009223:0.008104:0.005866:0.003024:0.009782:0.010326:0.003024:0.004188:0.002298:0.005866:0.003024:0.010175:0.009223:0.005866:0.004188:0.004188:0.002298:0.005866:0.009192:0.009782:0.009223:0.004188:0.002283:0.010326:0.005866:0.004188:0.002298:0.010311:0.009827:0.010357:0.010326:0.003024:0.004188
oedema and cyanosis:@0.096344:0.127430:0.261142:0.127430:0.261142:0.111647:0.096344:0.111647:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.004188:0.010326:0.009223:0.010357:0.004188:0.009782:0.008104:0.010326:0.009223:0.009903:0.005866:0.003024:0.005866
•  Poor social circumstances that may delay travel to a :@0.076190:0.141596:0.485130:0.141596:0.485130:0.125814:0.076190:0.125814:0.009162:0.004188:0.006804:0.008950:0.009903:0.009903:0.004551:0.004007:0.005866:0.009903:0.009782:0.003024:0.010326:0.003024:0.004037:0.009782:0.003024:0.004551:0.009782:0.009192:0.014182:0.005866:0.005125:0.010326:0.009223:0.009782:0.009827:0.005866:0.004022:0.005125:0.009223:0.010326:0.005125:0.004022:0.014182:0.010326:0.008104:0.004037:0.010357:0.009827:0.003024:0.010326:0.008104:0.004037:0.005125:0.004551:0.010326:0.008376:0.009827:0.003024:0.004022:0.005125:0.009903:0.004022:0.010326:0.004188
hospital or home support:@0.096344:0.155763:0.278559:0.155763:0.278559:0.139980:0.096344:0.139980:0.009223:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.004188:0.009903:0.004551:0.004188:0.009223:0.009903:0.014182:0.009827:0.004188:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125
•  The presence of comorbidities, such as heart failure :@0.076190:0.169929:0.485115:0.169929:0.485115:0.154146:0.076190:0.154146:0.009162:0.004188:0.006804:0.006441:0.009223:0.009827:0.005443:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.009782:0.009827:0.005443:0.009903:0.004747:0.005458:0.009782:0.009903:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.003024:0.009827:0.005866:0.004188:0.005458:0.005866:0.009192:0.009782:0.009223:0.005458:0.010326:0.005866:0.005458:0.009223:0.009827:0.010326:0.004551:0.005125:0.005443:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188
or arrhythmia.:@0.096344:0.184095:0.197808:0.184095:0.197808:0.168312:0.096344:0.168312:0.009903:0.004551:0.004188:0.010326:0.004551:0.004551:0.009223:0.008104:0.005125:0.009223:0.014182:0.003024:0.010326:0.004188
purulent sputum suggests a superadded bacterial in-:@0.090478:0.198261:0.480942:0.198261:0.480942:0.182479:0.090478:0.182479:0.008950:0.009192:0.004551:0.009192:0.003024:0.009827:0.009223:0.005125:0.005080:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.005095:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.005866:0.005095:0.010326:0.005095:0.005866:0.009192:0.010311:0.009827:0.004551:0.010326:0.010357:0.010357:0.009827:0.010357:0.005095:0.010311:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.010326:0.003024:0.005095:0.003024:0.009223:0.005020
fection and should be treated with an antibiotic. Green :@0.076190:0.212428:0.485115:0.212428:0.485115:0.196645:0.076190:0.196645:0.004747:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.003901:0.010326:0.009223:0.010357:0.003901:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003901:0.010311:0.009827:0.003901:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.003901:0.012564:0.003024:0.005125:0.009223:0.003901:0.010326:0.009223:0.003901:0.010326:0.009223:0.005125:0.003024:0.010311:0.003024:0.009903:0.005125:0.003024:0.009782:0.004188:0.003901:0.013184:0.004551:0.009827:0.009827:0.009223:0.004188
or yellow sputum in a multicentre study was culture-pos-:@0.076190:0.226594:0.480957:0.226594:0.480957:0.210811:0.076190:0.210811:0.009903:0.004551:0.003780:0.008104:0.009827:0.003024:0.003024:0.009903:0.012564:0.003795:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.003795:0.003024:0.009223:0.003795:0.010326:0.003795:0.014182:0.009192:0.003024:0.005125:0.003024:0.009782:0.009827:0.009223:0.005125:0.004551:0.009827:0.003780:0.005866:0.005125:0.009192:0.010357:0.008104:0.003795:0.012564:0.010326:0.005866:0.003795:0.009782:0.009192:0.003024:0.005125:0.009192:0.004551:0.009827:0.005020:0.010311:0.009903:0.005866:0.005020
itive in 58.9% and 45.5% of samples respectively, when :@0.076190:0.240760:0.485145:0.240760:0.485145:0.224978:0.076190:0.224978:0.003024:0.005125:0.003024:0.008376:0.009827:0.005564:0.003024:0.009223:0.005549:0.008376:0.008376:0.004188:0.008376:0.011717:0.005564:0.010326:0.009223:0.010357:0.005549:0.008376:0.008376:0.004188:0.008376:0.011717:0.005564:0.009903:0.004747:0.005549:0.005866:0.010326:0.014182:0.010311:0.003024:0.009827:0.005866:0.005564:0.004551:0.009827:0.005866:0.010311:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.003024:0.008104:0.004188:0.005549:0.012564:0.009223:0.009827:0.009223:0.004188
compared  to  clear sputum which yielded growth  in :@0.076190:0.254926:0.485145:0.254926:0.485145:0.239144:0.076190:0.239144:0.009782:0.009903:0.014182:0.010311:0.010326:0.004551:0.009827:0.010357:0.004188:0.003946:0.005125:0.009903:0.004188:0.003946:0.009782:0.003024:0.009827:0.010326:0.004551:0.008149:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.008149:0.012564:0.009223:0.003024:0.009782:0.009223:0.008149:0.008104:0.003024:0.009827:0.003024:0.010357:0.009827:0.010357:0.008149:0.010175:0.004551:0.009903:0.012564:0.005125:0.009223:0.004188:0.003946:0.003024:0.009223:0.004188
18% of cases.  In this study, the most common bacte-:@0.076190:0.269093:0.480929:0.269147:0.480929:0.253365:0.076190:0.253310:0.008376:0.008376:0.011717:0.005624:0.009903:0.004747:0.005609:0.009782:0.010326:0.005866:0.009827:0.005866:0.004188:0.009724:0.005609:0.003417:0.009223:0.005609:0.005125:0.009223:0.003024:0.005866:0.005624:0.005866:0.005125:0.009192:0.010357:0.008104:0.004188:0.005609:0.005125:0.009223:0.009827:0.005609:0.014182:0.009903:0.005866:0.005125:0.005609:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.005609:0.010311:0.010326:0.009782:0.005125:0.009827:0.501827
17:@0.176404:0.263849:0.186120:0.263849:0.186120:0.254695:0.176404:0.254695:0.004858:0.004858
rial isolate was :@0.076193:0.283313:0.187257:0.283313:0.187257:0.267531:0.076193:0.267531:0.004551:0.003024:0.010326:0.003024:0.005050:0.003024:0.005866:0.009903:0.003024:0.010326:0.005125:0.009827:0.005050:0.012564:0.010326:0.005866:0.004188
Haemophilus influenzae. :@0.188119:0.283313:0.371150:0.283313:0.371150:0.267531:0.188119:0.267531:0.010326:0.010326:0.009827:0.014182:0.009903:0.010311:0.009223:0.003024:0.003024:0.009192:0.005866:0.005050:0.003024:0.009223:0.003666:0.003666:0.009192:0.009827:0.009223:0.006426:0.010326:0.009827:0.004188:0.004188
It was twice as :@0.371997:0.283313:0.485148:0.283313:0.485148:0.267531:0.371997:0.267531:0.003417:0.005125:0.005050:0.012564:0.010326:0.005866:0.005050:0.005125:0.012564:0.003024:0.009782:0.009827:0.005050:0.010326:0.005866:0.004188
common  as :@0.076193:0.297480:0.170354:0.297480:0.170354:0.281697:0.076193:0.281697:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004188:0.002419:0.010326:0.005866:0.004188
Streptococcus  pneumoniae:@0.172788:0.297480:0.381113:0.297480:0.381113:0.281697:0.172788:0.281697:0.007529:0.005125:0.004551:0.009827:0.010311:0.005125:0.009903:0.009782:0.009903:0.009782:0.009782:0.009192:0.005866:0.004188:0.002419:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009223:0.003024:0.010326:0.009827
 or :@0.381113:0.297480:0.406377:0.297480:0.406377:0.281697:0.381113:0.281697:0.006622:0.009903:0.004551:0.004188
Moraxella :@0.408812:0.297480:0.485132:0.297480:0.485132:0.281697:0.408812:0.281697:0.013894:0.009903:0.004551:0.010326:0.007257:0.009827:0.003024:0.003024:0.010326:0.004188
catarrhalis:@0.076193:0.311646:0.152317:0.311646:0.152317:0.295863:0.076193:0.295863:0.009782:0.010326:0.005125:0.010326:0.004551:0.004551:0.009223:0.010326:0.003024:0.003024:0.005866
.:@0.152317:0.311646:0.156505:0.311646:0.156505:0.295863:0.152317:0.295863:0.004188
the acute care bundle of a non-life-threatening exac-:@0.076193:0.333513:0.480929:0.333513:0.480929:0.317015:0.076193:0.317015:0.006350:0.009071:0.009676:0.005337:0.009979:0.009676:0.009071:0.004536:0.009676:0.005337:0.009676:0.009979:0.004838:0.009676:0.005337:0.009979:0.009071:0.009071:0.009979:0.003629:0.009676:0.005337:0.009676:0.004233:0.005337:0.009979:0.005337:0.009071:0.009676:0.009071:0.006350:0.003629:0.003629:0.004233:0.009676:0.006350:0.004536:0.009071:0.004838:0.009676:0.009979:0.004536:0.009676:0.009071:0.003629:0.009071:0.009979:0.005322:0.009676:0.008467:0.009979:0.009676:0.006350
erbation consists of determining the presence of respir-:@0.076193:0.347679:0.480944:0.347679:0.480944:0.331181:0.076193:0.331181:0.009676:0.004838:0.009979:0.009979:0.004536:0.003629:0.009676:0.009071:0.004611:0.009676:0.009676:0.009071:0.006652:0.003629:0.006652:0.004536:0.006652:0.004596:0.009676:0.004233:0.004596:0.009979:0.009676:0.004536:0.009676:0.004838:0.014212:0.003629:0.009071:0.003629:0.009071:0.009979:0.004596:0.004536:0.009071:0.009676:0.004611:0.009979:0.004838:0.009676:0.006652:0.009676:0.009071:0.009676:0.009676:0.004611:0.009676:0.004233:0.004596:0.004838:0.009676:0.006652:0.009979:0.003629:0.004838:0.006350
atory failure, i.e.:@0.076193:0.361846:0.193516:0.361846:0.193516:0.345347:0.076193:0.345347:0.009979:0.004536:0.009676:0.004838:0.008769:0.004233:0.004233:0.009979:0.003629:0.003629:0.009071:0.004838:0.009676:0.004233:0.004233:0.003629:0.004233:0.009676:0.004233
•  Respiratory  rate  (RR)  above  30  breaths  per  minute :@0.076193:0.376012:0.485117:0.376012:0.485117:0.360229:0.076193:0.360229:0.009162:0.004188:0.006804:0.009177:0.009827:0.005866:0.010311:0.003024:0.004551:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.002737:0.004551:0.010326:0.005125:0.009827:0.004188:0.002737:0.005579:0.009177:0.009177:0.005579:0.004188:0.002737:0.010326:0.010311:0.009903:0.008376:0.009827:0.004188:0.002737:0.008376:0.008376:0.004188:0.002752:0.010311:0.004551:0.009827:0.010326:0.005125:0.009223:0.005866:0.004188:0.002737:0.010311:0.009827:0.004551:0.004188:0.002737:0.014182:0.003024:0.009223:0.009192:0.005125:0.009827:0.004188
(b/min):@0.096346:0.390178:0.150851:0.390178:0.150851:0.374396:0.096346:0.374396:0.005579:0.010311:0.006607:0.014182:0.003024:0.009223:0.005579
•  Accessory  muscle  use,  with  improvement  on  sup:@0.076193:0.404344:0.475925:0.404344:0.475925:0.388562:0.076193:0.388562:0.009162:0.004188:0.006804:0.011188:0.009782:0.009782:0.009827:0.005866:0.005866:0.009903:0.004551:0.008104:0.004188:0.004279:0.014182:0.009192:0.005866:0.009782:0.003024:0.009827:0.004188:0.004279:0.009192:0.005866:0.009827:0.004188:0.004188:0.004279:0.012564:0.003024:0.005125:0.009223:0.004188:0.004279:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.004279:0.009903:0.009223:0.004188:0.004279:0.005866:0.009192:0.010311
-:@0.475925:0.404344:0.480944:0.404344:0.480944:0.388562:0.475925:0.388562:0.005020
plemental oxygenation by venturi mask of 24-30% O  :@0.096346:0.418511:0.485140:0.418549:0.485140:0.402766:0.096346:0.402728:0.010311:0.003024:0.009827:0.014182:0.009827:0.009223:0.005125:0.010326:0.003024:0.004158:0.009903:0.007257:0.008104:0.010175:0.009827:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.004143:0.010311:0.008104:0.004158:0.008376:0.009827:0.009223:0.005125:0.009192:0.004551:0.003024:0.004143:0.014182:0.010326:0.005866:0.007590:0.004158:0.009903:0.004747:0.004143:0.008376:0.008376:0.005020:0.008376:0.008376:0.011717:0.004158:0.013138:0.004861:0.301140
2:@0.476092:0.418215:0.480950:0.418215:0.480950:0.409061:0.476092:0.409061:0.004858
and no change in mental status with a paCO  of 50-:@0.096354:0.432715:0.480942:0.432719:0.480942:0.416937:0.096354:0.416933:0.010326:0.009223:0.010357:0.004536:0.009223:0.009903:0.004521:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.004536:0.003024:0.009223:0.004536:0.014182:0.009827:0.009223:0.005125:0.010326:0.003024:0.004536:0.005866:0.005125:0.010326:0.005125:0.009192:0.005866:0.004536:0.012564:0.003024:0.005125:0.009223:0.004536:0.010326:0.004536:0.008950:0.010326:0.012292:0.013138:0.004829:0.004536:0.009903:0.004747:0.004521:0.008376:0.008376:0.287612
2:@0.430605:0.432385:0.435463:0.432385:0.435463:0.423231:0.430605:0.423231:0.004858
60 mmHg.:@0.096344:0.446886:0.170337:0.446886:0.170337:0.431103:0.096344:0.431103:0.008376:0.008376:0.004188:0.014182:0.014182:0.010326:0.010175:0.004188
1:@0.170342:0.441591:0.175200:0.441591:0.175200:0.432437:0.170342:0.432437:0.004858
the Gold guidelines suggest the following therapy::@0.076190:0.468757:0.444188:0.468757:0.444188:0.452259:0.076190:0.452259:0.006350:0.009071:0.009676:0.004233:0.012700:0.009676:0.003629:0.009979:0.004233:0.009979:0.009071:0.003629:0.009979:0.009676:0.003629:0.003629:0.009071:0.009676:0.006652:0.004233:0.006652:0.009071:0.009979:0.009979:0.009676:0.006652:0.004536:0.004233:0.004536:0.009071:0.009676:0.004233:0.004233:0.009676:0.003629:0.003629:0.009676:0.012095:0.003629:0.009071:0.009979:0.004233:0.004536:0.009071:0.009676:0.004838:0.009979:0.009979:0.008769:0.004233
1:@0.444163:0.463459:0.449074:0.463459:0.449074:0.453890:0.444163:0.453890:0.004911
•  If  the  sputum  is  purulent,  antibiotics  are  indicated :@0.076190:0.482928:0.485130:0.482928:0.485130:0.467145:0.076190:0.467145:0.009162:0.004188:0.006804:0.003417:0.004747:0.004188:0.003583:0.005125:0.009223:0.009827:0.004188:0.003583:0.005866:0.010311:0.009192:0.005125:0.009192:0.014182:0.004188:0.003583:0.003024:0.005866:0.004188:0.003583:0.010311:0.009192:0.004551:0.009192:0.003024:0.009827:0.009223:0.005125:0.004188:0.004188:0.003568:0.010326:0.009223:0.005125:0.003024:0.010311:0.003024:0.009903:0.005125:0.003024:0.009782:0.005866:0.004188:0.003583:0.010326:0.004551:0.009827:0.004188:0.003583:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.004188
and a five- to seven-day course is given with a five-:@0.096344:0.497094:0.480927:0.497094:0.480927:0.481312:0.096344:0.481312:0.010326:0.009223:0.010357:0.005231:0.010326:0.005231:0.003681:0.003681:0.008376:0.009827:0.005020:0.005231:0.005125:0.009903:0.005231:0.005866:0.009827:0.008376:0.009827:0.009223:0.005020:0.010357:0.010326:0.008104:0.005231:0.009782:0.009903:0.009192:0.004551:0.005866:0.009827:0.005231:0.003024:0.005866:0.005246:0.010175:0.003024:0.008376:0.009827:0.009223:0.005231:0.012564:0.003024:0.005125:0.009223:0.005231:0.010326:0.005231:0.003681:0.003681:0.008376:0.009827:0.005020
day course of 40 mg of prednisone daily.:@0.096344:0.511260:0.395111:0.511260:0.395111:0.495478:0.096344:0.495478:0.010357:0.010326:0.008104:0.004188:0.009782:0.009903:0.009192:0.004551:0.005866:0.009827:0.004188:0.009903:0.004747:0.004188:0.008376:0.008376:0.004188:0.014182:0.010175:0.004188:0.009903:0.004747:0.004188:0.010311:0.004551:0.009827:0.010357:0.009223:0.003024:0.005866:0.009903:0.009223:0.009827:0.004188:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188
•  Combined  SABA  and  SAMA  nebulisation  is  given, :@0.076190:0.525427:0.485130:0.525427:0.485130:0.509644:0.076190:0.509644:0.009162:0.004188:0.006804:0.012292:0.009903:0.014182:0.010311:0.003024:0.009223:0.009827:0.010357:0.004188:0.004385:0.007529:0.011188:0.008678:0.011188:0.004188:0.004385:0.010326:0.009223:0.010357:0.004188:0.004385:0.007529:0.011188:0.013894:0.011188:0.004188:0.004369:0.009223:0.009827:0.010311:0.009192:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004385:0.003024:0.005866:0.004188:0.004385:0.010175:0.003024:0.008376:0.009827:0.009223:0.004188:0.004188
and the frequency is increased.:@0.096344:0.539593:0.328603:0.539593:0.328603:0.523810:0.096344:0.523810:0.010326:0.009223:0.010357:0.004188:0.005125:0.009223:0.009827:0.004188:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.009782:0.008104:0.004188:0.003024:0.005866:0.004188:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004188
•  Do a chest-x ray to exclude a pneumothorax, car:@0.076190:0.553759:0.475938:0.553759:0.475938:0.537977:0.076190:0.537977:0.009162:0.004188:0.006804:0.011249:0.009903:0.006320:0.010326:0.006320:0.009782:0.009223:0.009827:0.005866:0.005125:0.005020:0.007257:0.006320:0.004551:0.010326:0.008104:0.006320:0.005125:0.009903:0.006320:0.009827:0.007257:0.009782:0.003024:0.009192:0.010357:0.009827:0.006320:0.010326:0.006320:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.005125:0.009223:0.009903:0.004551:0.010326:0.007257:0.004188:0.006305:0.009782:0.010326:0.004551
-:@0.475938:0.553759:0.480957:0.553759:0.480957:0.537977:0.475938:0.537977:0.005020
diac failure and pneumonia.:@0.096344:0.567925:0.306393:0.567925:0.306393:0.552143:0.096344:0.552143:0.010357:0.003024:0.010326:0.009782:0.004188:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009223:0.003024:0.010326:0.004188
•  Life-threatening respiratory failure requires mechani:@0.076190:0.582092:0.475923:0.582092:0.475923:0.566309:0.076190:0.566309:0.009162:0.004188:0.006804:0.006985:0.003024:0.004747:0.009827:0.005020:0.005125:0.009223:0.004551:0.009827:0.010326:0.005125:0.009827:0.009223:0.003024:0.009223:0.010175:0.005186:0.004551:0.009827:0.005866:0.010311:0.003024:0.004551:0.010326:0.005125:0.009903:0.004551:0.008104:0.005186:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005201:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.005866:0.005186:0.014182:0.009827:0.009782:0.009223:0.010326:0.009223:0.003024
-:@0.475923:0.582092:0.480942:0.582092:0.480942:0.566309:0.475923:0.566309:0.005020
cal ventilation with RR >30 b/min, accessory muscle :@0.096344:0.596258:0.485130:0.596258:0.485130:0.580475:0.096344:0.580475:0.009782:0.010326:0.003024:0.005382:0.008376:0.009827:0.009223:0.005125:0.003024:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005382:0.012564:0.003024:0.005125:0.009223:0.005382:0.009177:0.009177:0.005367:0.009162:0.008376:0.008376:0.005382:0.010311:0.006607:0.014182:0.003024:0.009223:0.004188:0.005367:0.010326:0.009782:0.009782:0.009827:0.005866:0.005866:0.009903:0.004551:0.008104:0.005382:0.014182:0.009192:0.005866:0.009782:0.003024:0.009827:0.004188
use with change in mental state, a pH  7.25, paCO  :@0.096344:0.610424:0.485140:0.610462:0.485140:0.594679:0.096344:0.594642:0.009192:0.005866:0.009827:0.004838:0.012564:0.003024:0.005125:0.009223:0.004853:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.004838:0.003024:0.009223:0.004853:0.014182:0.009827:0.009223:0.005125:0.010326:0.003024:0.004838:0.005866:0.005125:0.010326:0.005125:0.009827:0.004188:0.004838:0.010326:0.004853:0.010311:0.010326:0.004188:0.009827:0.008376:0.004188:0.008376:0.008376:0.004188:0.004853:0.008950:0.010326:0.012292:0.013138:0.004863:0.049825
<:@0.383863:0.610424:0.393025:0.610424:0.393025:0.594642:0.383863:0.594642:0.009162
2:@0.476092:0.610128:0.480950:0.610128:0.480950:0.600974:0.476092:0.600974:0.004858
>60 mmHg and hypoxaemia still present on FiO  of :@0.096354:0.624628:0.485150:0.624632:0.485150:0.608850:0.096354:0.608846:0.009162:0.008376:0.008376:0.006320:0.014182:0.014182:0.010326:0.010175:0.006305:0.010326:0.009223:0.010357:0.006320:0.009223:0.008104:0.010311:0.009903:0.007257:0.010326:0.009827:0.014182:0.003024:0.010326:0.006320:0.005866:0.005125:0.003024:0.003024:0.003024:0.006320:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.006305:0.009903:0.009223:0.006305:0.007333:0.003024:0.013138:0.004864:0.006320:0.009903:0.004747:0.031258
2:@0.455132:0.624298:0.459990:0.624298:0.459990:0.615144:0.455132:0.615144:0.004858
60%. If no  contra-indication  exists, consider  non-in-:@0.096349:0.638799:0.480962:0.638799:0.480962:0.623016:0.096349:0.623016:0.008376:0.008376:0.011717:0.004188:0.007242:0.003417:0.004747:0.007242:0.009223:0.009903:0.004188:0.003039:0.009782:0.009903:0.009223:0.005125:0.004551:0.010326:0.005020:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003039:0.009827:0.007257:0.003024:0.005866:0.005125:0.005866:0.004188:0.007242:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.004188:0.003039:0.009223:0.009903:0.009223:0.005020:0.003024:0.009223:0.005020
vasive mechanical ventilation before invasive venti-:@0.096349:0.652965:0.480962:0.652965:0.480962:0.637182:0.096349:0.637182:0.008376:0.010326:0.005866:0.003024:0.008376:0.009827:0.005231:0.014182:0.009827:0.009782:0.009223:0.010326:0.009223:0.003024:0.009782:0.010326:0.003024:0.005216:0.008376:0.009827:0.009223:0.005125:0.003024:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005216:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.005201:0.003024:0.009223:0.008376:0.010326:0.005866:0.003024:0.008376:0.009827:0.005231:0.008376:0.009827:0.009223:0.005125:0.003024:0.005020
lation since there is a better gas exchange and the :@0.096349:0.667131:0.485135:0.667131:0.485135:0.651349:0.096349:0.651349:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005292:0.005866:0.003024:0.009223:0.009782:0.009827:0.005292:0.005125:0.009223:0.009827:0.004551:0.009827:0.005277:0.003024:0.005866:0.005307:0.010326:0.005292:0.010311:0.009827:0.005125:0.005125:0.009827:0.004551:0.005292:0.010175:0.010326:0.005866:0.005292:0.009827:0.007257:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.005292:0.010326:0.009223:0.010357:0.005292:0.005125:0.009223:0.009827:0.004188
work of breathing can be supported.:@0.096349:0.681298:0.367434:0.681298:0.367434:0.665515:0.096349:0.665515:0.012564:0.009903:0.004551:0.007590:0.004188:0.009903:0.004747:0.004188:0.010311:0.004551:0.009827:0.010326:0.005125:0.009223:0.003024:0.009223:0.010175:0.004188:0.009782:0.010326:0.009223:0.004188:0.010311:0.009827:0.004188:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.009827:0.010357:0.004188
PrOGressiOn Of COPD :@0.076190:0.714232:0.295349:0.714232:0.295349:0.694067:0.076190:0.694067:0.010348:0.010718:0.015522:0.015522:0.010718:0.009609:0.009609:0.009609:0.005174:0.015522:0.013674:0.005174:0.015522:0.008870:0.005174:0.014413:0.015522:0.010348:0.012935:0.005174
Continued cigarette-smoking is the most significant fac:@0.076190:0.730181:0.475923:0.730181:0.475923:0.714398:0.076190:0.714398:0.012292:0.009903:0.009223:0.005125:0.003024:0.009223:0.009192:0.009827:0.010357:0.003780:0.009782:0.003024:0.010175:0.010326:0.004551:0.009827:0.005125:0.005125:0.009827:0.005020:0.005866:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.003780:0.003024:0.005866:0.003795:0.005125:0.009223:0.009827:0.003780:0.014182:0.009903:0.005866:0.005125:0.003780:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.003780:0.004747:0.010326:0.009782
-:@0.475923:0.730181:0.480942:0.730181:0.480942:0.714398:0.475923:0.714398:0.005020
tor in the progression of COpD. Exacerbations result in :@0.076190:0.744347:0.485130:0.744347:0.485130:0.728564:0.076190:0.728564:0.005125:0.009903:0.004551:0.005942:0.003024:0.009223:0.005957:0.005125:0.009223:0.009827:0.005957:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.005942:0.009903:0.004747:0.005957:0.012292:0.013138:0.008950:0.011249:0.004188:0.005957:0.008104:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.005957:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005957:0.003024:0.009223:0.004188
further lung damage and cause further exacerbations. :@0.076190:0.758513:0.485145:0.758513:0.485145:0.742730:0.076190:0.742730:0.004747:0.009192:0.004551:0.005125:0.009223:0.009827:0.004551:0.004838:0.003024:0.009192:0.009223:0.010175:0.004853:0.010357:0.010326:0.014182:0.010326:0.010175:0.009827:0.004853:0.010326:0.009223:0.010357:0.004853:0.009782:0.010326:0.009192:0.005866:0.009827:0.004853:0.004747:0.009192:0.004551:0.005125:0.009223:0.009827:0.004551:0.004838:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004188
smoking  cessation,  prevention of exacerbations and :@0.076190:0.772679:0.485145:0.772679:0.485145:0.756897:0.076190:0.756897:0.007529:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.004188:0.003946:0.009782:0.009827:0.005866:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.003946:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.008149:0.009903:0.004747:0.008149:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.008149:0.010326:0.009223:0.010357:0.004188
treatment of oesophageal reflux, if present, will limit ex:@0.076190:0.786846:0.475938:0.786846:0.475938:0.771063:0.076190:0.771063:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004611:0.009903:0.004747:0.004611:0.009903:0.009827:0.005866:0.009903:0.010311:0.009223:0.010326:0.010175:0.009827:0.010326:0.003024:0.004611:0.004551:0.009827:0.003666:0.003666:0.009192:0.007257:0.004188:0.004611:0.003024:0.004747:0.004626:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.004188:0.004611:0.012564:0.003024:0.003024:0.003024:0.004626:0.003024:0.003024:0.014182:0.003024:0.005125:0.004626:0.009827:0.007257
-:@0.475938:0.786846:0.480957:0.786846:0.480957:0.771063:0.475938:0.771063:0.005020
acerbations and the progression of the disease.  :@0.076190:0.801012:0.441275:0.801033:0.441275:0.785250:0.076190:0.785229:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.005125:0.009223:0.009827:0.004188:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.009903:0.004747:0.004188:0.005125:0.009223:0.009827:0.004188:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.012116:-0.155867
8,1:@0.424940:0.795734:0.437085:0.795734:0.437085:0.786580:0.424940:0.786580:0.004858:0.002429:0.004858
referenCes:@0.076190:0.833951:0.182628:0.833951:0.182628:0.813786:0.076190:0.813786:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1.   Alvar A, :@0.076190:0.845904:0.149627:0.845904:0.149627:0.833629:0.076190:0.833629:0.006515:0.003257:0.003257:0.003257:0.008914:0.008702:0.002352:0.006515:0.008032:0.003540:0.003881:0.008702:0.003257:0.003257
et al:@0.150250:0.845904:0.176144:0.845904:0.176144:0.833629:0.150250:0.833629:0.007644:0.003986:0.003881:0.008032:0.002352
. Global Initiative for chronic obstructive lung disease :@0.176144:0.845904:0.484201:0.845904:0.484201:0.833629:0.176144:0.833629:0.003257:0.003881:0.010254:0.002352:0.007702:0.008020:0.008032:0.002352:0.003892:0.002658:0.007173:0.002352:0.003986:0.002352:0.008032:0.003986:0.002352:0.006515:0.007644:0.003892:0.003692:0.007702:0.003540:0.003881:0.007608:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.003881:0.007702:0.008020:0.004563:0.003986:0.003540:0.007150:0.007608:0.003986:0.002352:0.006515:0.007644:0.003881:0.002352:0.007150:0.007173:0.007914:0.003881:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257
[Internet].  2018. Available from:  http://www.who.int/respiratory/:@0.101390:0.856869:0.480967:0.856869:0.480967:0.844593:0.101390:0.844593:0.004127:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.007644:0.003986:0.004127:0.003257:0.003257:0.004621:0.006515:0.006515:0.006515:0.006515:0.003257:0.007890:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.007890:0.003692:0.003540:0.007702:0.011030:0.003257:0.003257:0.004621:0.007173:0.003986:0.003986:0.008020:0.003257:0.005139:0.005139:0.009772:0.009772:0.009772:0.003257:0.009772:0.007173:0.007702:0.003257:0.002352:0.007173:0.003986:0.005139:0.003540:0.007644:0.004563:0.008020:0.002352:0.003540:0.008032:0.003986:0.007702:0.003540:0.006303:0.005139
copd/GOLD_WR_06.pdf:@0.101390:0.867833:0.238809:0.867833:0.238809:0.855558:0.101390:0.855558:0.007608:0.007702:0.008020:0.008055:0.005139:0.010254:0.010219:0.005433:0.008749:0.005880:0.011289:0.007138:0.005880:0.006515:0.006515:0.003257:0.008020:0.008055:0.003692
2.   sundeep  s,  Barnes  p.  Chronic  obstructive  pulmonary  disease in :@0.076190:0.878797:0.484201:0.878797:0.484201:0.866522:0.076190:0.866522:0.006515:0.003257:0.003257:0.003257:0.008914:0.005856:0.007150:0.007173:0.008055:0.007644:0.007644:0.008020:0.003257:0.002881:0.005856:0.003257:0.003257:0.002881:0.006750:0.008032:0.003540:0.007173:0.007644:0.004563:0.003257:0.002893:0.006961:0.003257:0.003257:0.002881:0.009560:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.003257:0.002881:0.007702:0.008020:0.004563:0.003986:0.003540:0.007150:0.007608:0.003986:0.002352:0.006515:0.007644:0.003257:0.002881:0.008020:0.007150:0.002352:0.011030:0.007702:0.007173:0.008032:0.003540:0.006303:0.003257:0.002881:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.006150:0.002352:0.007173:0.003257
non-smokers. :@0.101390:0.889762:0.178802:0.889762:0.178802:0.877486:0.101390:0.877486:0.007173:0.007702:0.007173:0.003904:0.004563:0.011030:0.007702:0.005903:0.007644:0.003540:0.004563:0.003257:0.003257
Lancet:@0.178790:0.889762:0.218665:0.889762:0.218665:0.877486:0.178790:0.877486:0.005433:0.008032:0.007173:0.007608:0.007644:0.003986
. 2009;374(9691):733-45. :@0.218665:0.889762:0.355026:0.889762:0.355026:0.877486:0.218665:0.877486:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.003257
3.   Ehrlich RI, White N, Norman R, :@0.076190:0.900726:0.267408:0.900726:0.267408:0.888451:0.076190:0.888451:0.006397:0.003140:0.003140:0.003257:0.009266:0.006185:0.007056:0.003422:0.002234:0.002234:0.007491:0.007056:0.003034:0.007020:0.002540:0.003140:0.003034:0.011171:0.007056:0.002234:0.003869:0.007526:0.003034:0.008584:0.003140:0.003034:0.008584:0.007585:0.003422:0.010913:0.007914:0.007056:0.003034:0.007020:0.003140:0.003257
et al:@0.267184:0.900726:0.291879:0.900726:0.291879:0.888451:0.267184:0.888451:0.007526:0.003869:0.003034:0.007914:0.002352
. predictors of chronic bronchitis in :@0.291761:0.900726:0.484295:0.900726:0.484295:0.888451:0.291761:0.888451:0.003140:0.003034:0.006844:0.003422:0.007526:0.007937:0.002234:0.007491:0.003869:0.007585:0.003422:0.004445:0.003034:0.007585:0.003575:0.003034:0.007491:0.007056:0.003422:0.007585:0.007056:0.002234:0.007491:0.003034:0.007902:0.003422:0.007585:0.007056:0.007491:0.007056:0.002234:0.003869:0.002234:0.004445:0.003034:0.002234:0.007173:0.003257
south African adults. :@0.101390:0.911690:0.219054:0.911690:0.219054:0.899415:0.101390:0.899415:0.005739:0.007585:0.007032:0.003869:0.007056:0.003140:0.008584:0.003575:0.003422:0.002234:0.007491:0.007914:0.007056:0.003140:0.007914:0.007937:0.007032:0.002234:0.003869:0.004445:0.003140:0.003257
Int J Tuberc Lung Dis:@0.218936:0.911690:0.331401:0.911690:0.331401:0.899415:0.218936:0.899415:0.002540:0.007056:0.003869:0.003140:0.005550:0.003140:0.004892:0.007032:0.007902:0.007526:0.003422:0.007491:0.003140:0.005315:0.007032:0.007056:0.007796:0.003140:0.008631:0.002234:0.004563
. 2004;8(June 2003):369-76. :@0.331284:0.911690:0.482449:0.911690:0.482449:0.899415:0.331284:0.899415:0.003140:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.004222:0.005550:0.007032:0.007056:0.007526:0.003140:0.006397:0.006397:0.006397:0.006397:0.004222:0.003140:0.006397:0.006397:0.006397:0.003786:0.006397:0.006397:0.003257:0.003257
4.   Blasi F, Cesana G, Conti s, :@0.076190:0.922655:0.252767:0.922655:0.252767:0.910379:0.076190:0.910379:0.006515:0.003257:0.003257:0.003257:0.008914:0.006750:0.002352:0.008032:0.004563:0.002352:0.003351:0.005703:0.003257:0.003340:0.009560:0.007644:0.004563:0.008032:0.007173:0.008032:0.003340:0.010254:0.003257:0.003340:0.009560:0.007702:0.007173:0.003986:0.002352:0.003340:0.005856:0.003257:0.003257
et al.:@0.252850:0.922655:0.281460:0.922655:0.281460:0.910379:0.252850:0.910379:0.007644:0.003986:0.003340:0.008032:0.002352:0.003257
 The clinical and economic impact :@0.281460:0.922655:0.484189:0.922655:0.484189:0.910379:0.281460:0.910379:0.003340:0.005009:0.007173:0.007644:0.003340:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003351:0.008032:0.007173:0.008055:0.003340:0.007644:0.007608:0.007702:0.007173:0.007702:0.011030:0.002352:0.007608:0.003340:0.002352:0.011030:0.008020:0.008032:0.007608:0.003986:0.003257
of exacerbations of chronic obstructive pulmonary disease: A co-:@0.101390:0.933619:0.480956:0.933619:0.480956:0.921344:0.101390:0.921344:0.007702:0.003692:0.004163:0.007644:0.005644:0.008032:0.007608:0.007644:0.003540:0.008020:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.004163:0.007702:0.003692:0.004163:0.007608:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.004151:0.007702:0.008020:0.004563:0.003986:0.003540:0.007150:0.007608:0.003986:0.002352:0.006515:0.007644:0.004163:0.008020:0.007150:0.002352:0.011030:0.007702:0.007173:0.008032:0.003540:0.006303:0.004163:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.004163:0.008702:0.004163:0.007608:0.007702:0.003904
hort of hospitalised patients. :@0.101390:0.944583:0.264021:0.944583:0.264021:0.932308:0.101390:0.932308:0.007173:0.007702:0.003540:0.003986:0.003257:0.007702:0.003692:0.003257:0.007173:0.007702:0.004563:0.008020:0.002352:0.003986:0.008032:0.002352:0.002352:0.004563:0.007644:0.008055:0.003257:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.003257:0.003257
Plos/one:@0.264009:0.944583:0.313245:0.944583:0.313245:0.932308:0.264009:0.932308:0.006961:0.002352:0.007702:0.004563:0.005139:0.007702:0.007173:0.007644
. 2014;9(6):1-8. :@0.313245:0.944583:0.397488:0.944583:0.397488:0.932308:0.313245:0.932308:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.003904:0.006515:0.003257:0.003257
5.   Barnes PJ. Inflammatory mechanisms in patients with chronic ob:@0.519056:0.082227:0.919928:0.082227:0.919928:0.069951:0.519056:0.069951:0.006515:0.003257:0.003257:0.003257:0.008914:0.006750:0.008032:0.003540:0.007173:0.007644:0.004563:0.004786:0.006961:0.005668:0.003257:0.004786:0.002658:0.007173:0.002852:0.002852:0.008032:0.011030:0.011030:0.008032:0.003986:0.007702:0.003540:0.006303:0.004786:0.011030:0.007644:0.007608:0.007173:0.008032:0.007173:0.002352:0.004563:0.011030:0.004563:0.004798:0.002352:0.007173:0.004786:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.004786:0.009772:0.002352:0.003986:0.007173:0.004786:0.007608:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.004774:0.007702:0.008020
-:@0.919928:0.082227:0.923832:0.082227:0.923832:0.069951:0.919928:0.069951:0.003904
structive pulmonary disease. :@0.544256:0.093128:0.717834:0.093128:0.717834:0.080853:0.544256:0.080853:0.004563:0.003986:0.003540:0.007150:0.007608:0.003986:0.002352:0.006515:0.007644:0.007785:0.008020:0.007150:0.002352:0.011030:0.007702:0.007173:0.008032:0.003540:0.006303:0.007785:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
J Allergy Clin Immunol:@0.722361:0.093128:0.860721:0.093128:0.860721:0.080853:0.722361:0.080853:0.005668:0.007785:0.008702:0.002352:0.002352:0.007644:0.003540:0.007914:0.006303:0.007785:0.009560:0.002352:0.002352:0.007173:0.007785:0.002658:0.011030:0.011030:0.007150:0.007173:0.007702:0.002352
 [Internet]. :@0.860721:0.093128:0.927078:0.093128:0.927078:0.080853:0.860721:0.080853:0.007785:0.004127:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.007644:0.003986:0.004127:0.003257:0.003257
2016;138(1):16-27.  Available from:  http://dx.doi.org/10.1016/j.:@0.544256:0.104030:0.923821:0.104030:0.923821:0.091754:0.544256:0.091754:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.003257:0.011218:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.014452:0.003692:0.003540:0.007702:0.011030:0.003257:0.003257:0.011183:0.007173:0.003986:0.003986:0.008020:0.003257:0.005139:0.005139:0.008055:0.005644:0.003257:0.008055:0.007702:0.002352:0.003257:0.007702:0.003540:0.007914:0.005139:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.005139:0.002387:0.003257
jaci.2016.05.011:@0.544256:0.114931:0.633038:0.114931:0.633038:0.102656:0.544256:0.102656:0.002387:0.008032:0.007608:0.002352:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515
6.   Barnes pJ, Foop M. Asthma-COpD overlap. :@0.519056:0.125833:0.781346:0.125833:0.781346:0.113557:0.519056:0.113557:0.006279:0.003022:0.003022:0.003257:0.009619:0.006515:0.007796:0.003304:0.006938:0.007408:0.004327:0.003022:0.006726:0.005433:0.003022:0.003022:0.005468:0.007467:0.007467:0.007785:0.003022:0.010572:0.003022:0.003022:0.008467:0.004327:0.003751:0.006938:0.010795:0.007796:0.003669:0.009325:0.009984:0.006726:0.008514:0.003022:0.007467:0.006279:0.007408:0.003304:0.002117:0.007796:0.007785:0.003022:0.003257
Chest:@0.781110:0.125833:0.813096:0.125833:0.813096:0.113557:0.781110:0.113557:0.009325:0.006938:0.007408:0.004327:0.003986
. 2016;149(1):2015-6.:@0.812860:0.125833:0.921716:0.125833:0.921716:0.113557:0.812860:0.113557:0.003022:0.003022:0.006279:0.006279:0.006279:0.006279:0.003022:0.006279:0.006279:0.006279:0.004104:0.006279:0.004104:0.003022:0.006279:0.006279:0.006279:0.006279:0.003669:0.006279:0.003257
7.   Halpin DMG, Maldon M. [Full text] Impact and prevention of severe :@0.519056:0.136734:0.927078:0.136734:0.927078:0.124459:0.519056:0.124459:0.006515:0.003257:0.003257:0.003257:0.008914:0.008032:0.008032:0.002352:0.008020:0.002352:0.007173:0.003010:0.008749:0.010807:0.010254:0.003257:0.002999:0.010807:0.008032:0.002352:0.008055:0.007702:0.007173:0.002999:0.010807:0.003257:0.002999:0.004127:0.005703:0.007150:0.002352:0.002352:0.002999:0.003986:0.007644:0.005644:0.003986:0.004127:0.002999:0.002658:0.011030:0.008020:0.008032:0.007608:0.003986:0.002999:0.008032:0.007173:0.008055:0.002999:0.008020:0.003540:0.007644:0.006515:0.007644:0.007173:0.003986:0.002352:0.007702:0.007173:0.002999:0.007702:0.003692:0.002999:0.004563:0.007644:0.006515:0.007644:0.003540:0.007644:0.003257
exacerbations of COpD. A review of COpD. :@0.544256:0.147636:0.791576:0.147636:0.791576:0.135360:0.544256:0.135360:0.007644:0.005644:0.008032:0.007608:0.007644:0.003540:0.008020:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.002611:0.007702:0.003692:0.002611:0.009560:0.010219:0.006961:0.008749:0.003257:0.002611:0.008702:0.002611:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.002622:0.007702:0.003692:0.002611:0.009560:0.010219:0.006961:0.008749:0.003257:0.003257
Int J Chronic Obstr Pulm :@0.790953:0.147636:0.927078:0.147636:0.927078:0.135360:0.790953:0.135360:0.002658:0.007173:0.003986:0.002611:0.005668:0.002611:0.009560:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.002611:0.010219:0.008020:0.004563:0.003986:0.003540:0.002622:0.006961:0.007150:0.002352:0.011030:0.003257
Dis:@0.544256:0.158537:0.559919:0.158537:0.559919:0.146262:0.544256:0.146262:0.008749:0.002352:0.004563
. 2017;12:2891-2908. :@0.559919:0.158537:0.674572:0.158537:0.674572:0.146262:0.559919:0.146262:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
8.   McDonald  M.  Chronic  obstructive  pulmonary  disease 8: :@0.519056:0.169439:0.927066:0.169439:0.927066:0.157163:0.519056:0.157163:0.006515:0.003257:0.003257:0.003257:0.008914:0.010807:0.007608:0.008749:0.007702:0.007173:0.008032:0.002352:0.008055:0.003257:0.010560:0.010807:0.003257:0.003257:0.010560:0.009560:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.003257:0.010560:0.007702:0.008020:0.004563:0.003986:0.003540:0.007150:0.007608:0.003986:0.002352:0.006515:0.007644:0.003257:0.010560:0.008020:0.007150:0.002352:0.011030:0.007702:0.007173:0.008032:0.003540:0.006303:0.003257:0.010560:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.013829:0.006515:0.003257:0.003257
non-pharmacological  management of  COpD:@0.544256:0.180340:0.837825:0.180340:0.837825:0.168065:0.544256:0.168065:0.007173:0.007702:0.007173:0.003904:0.008020:0.007173:0.008032:0.003540:0.011030:0.008032:0.007608:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.008032:0.002352:0.003257:0.010619:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003975:0.013888:0.007702:0.003692:0.003257:0.010619:0.009560:0.010219:0.006961:0.008749
. Thorax:@0.837825:0.180340:0.892071:0.180340:0.892071:0.168065:0.837825:0.168065:0.003257:0.013888:0.005009:0.007173:0.007702:0.003540:0.008032:0.005644
 [In-:@0.892071:0.180340:0.923821:0.180340:0.923821:0.168065:0.892071:0.168065:0.013888:0.004127:0.002658:0.007173:0.003904
ternet].  2003;58(5):453-7.  Available  from:  http://dw2zn6fm9z.:@0.544256:0.191241:0.923821:0.191241:0.923821:0.178966:0.544256:0.178966:0.003986:0.007644:0.003540:0.007173:0.007644:0.003986:0.004127:0.003257:0.003257:0.009666:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257:0.003257:0.009701:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.003257:0.009690:0.003692:0.003540:0.007702:0.011030:0.003257:0.003257:0.009666:0.007173:0.003986:0.003986:0.008020:0.003257:0.005139:0.005139:0.008055:0.009772:0.006515:0.004998:0.007173:0.006515:0.003692:0.011030:0.006515:0.004998:0.003257
search.serialssolutions.com/?url_ver=Z39.88-2004&rft_val_:@0.544256:0.202143:0.923738:0.202143:0.923738:0.189868:0.544256:0.189868:0.005597:0.008678:0.009066:0.004574:0.008643:0.008208:0.004292:0.005597:0.008678:0.004574:0.003387:0.009066:0.003387:0.005597:0.005597:0.008737:0.003387:0.008184:0.005021:0.003387:0.008737:0.008208:0.005597:0.004292:0.008643:0.008737:0.012065:0.006174:0.007985:0.008184:0.004574:0.003387:0.006914:0.007549:0.008678:0.004574:0.008161:0.006679:0.007549:0.007549:0.004292:0.007549:0.007549:0.004939:0.007549:0.007549:0.007549:0.007549:0.009937:0.004574:0.004727:0.005021:0.006914:0.007549:0.009066:0.003387:0.005880
fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/Ovid:med4&rft.:@0.544256:0.213044:0.923668:0.213044:0.923668:0.200769:0.544256:0.200769:0.004151:0.011489:0.004445:0.007585:0.002822:0.007632:0.004151:0.008161:0.003716:0.008161:0.004151:0.002822:0.005597:0.004151:0.011489:0.004445:0.003716:0.006362:0.008102:0.006985:0.003716:0.011489:0.004445:0.006103:0.003716:0.002857:0.008161:0.007608:0.003998:0.007632:0.008490:0.002822:0.009360:0.003998:0.004151:0.003998:0.006338:0.002822:0.008514:0.007585:0.002822:0.007632:0.004151:0.008161:0.003716:0.005033:0.002822:0.008514:0.005597:0.010689:0.006985:0.002822:0.008514:0.003716:0.011489:0.008102:0.008514:0.006985:0.009360:0.003998:0.004151:0.004445:0.003257
genre=article&rft_id=info:doi/&rft_id=info:pmid/12728173&rft.:@0.544256:0.223946:0.923774:0.223946:0.923774:0.211671:0.544256:0.211671:0.008478:0.008208:0.007738:0.004104:0.008208:0.007691:0.008608:0.004104:0.004551:0.002928:0.008184:0.002928:0.008208:0.009466:0.004104:0.004269:0.004551:0.006456:0.002928:0.008631:0.007702:0.002928:0.007738:0.004257:0.008267:0.003822:0.008631:0.008267:0.002928:0.005715:0.009466:0.004104:0.004257:0.004551:0.006444:0.002928:0.008631:0.007691:0.002928:0.007738:0.004257:0.008267:0.003822:0.008596:0.011606:0.002928:0.008631:0.005715:0.007091:0.007091:0.007091:0.007091:0.007091:0.007091:0.007091:0.007091:0.009466:0.004104:0.004257:0.004551:0.003257
issn=0040-6376&rft.volume=58&rft.issue=5&rft.spage=453&r:@0.544256:0.234847:0.873926:0.234847:0.873926:0.222572:0.544256:0.222572:0.002352:0.004563:0.004563:0.007173:0.007126:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.008902:0.003540:0.003692:0.003986:0.003257:0.006515:0.007702:0.002352:0.007150:0.011030:0.007644:0.007126:0.006515:0.006515:0.008902:0.003540:0.003692:0.003986:0.003257:0.002352:0.004563:0.004563:0.007150:0.007644:0.007126:0.006515:0.008902:0.003540:0.003692:0.003986:0.003257:0.004563:0.008020:0.008032:0.007914:0.007644:0.007126:0.006515:0.006515:0.006515:0.008902:0.003540
9.   Wongsurakiat p, Maranetra KN, Wasi C, Kositanont U, :@0.519056:0.245749:0.854100:0.245749:0.854100:0.233473:0.519056:0.233473:0.006515:0.003257:0.003257:0.003257:0.008914:0.011289:0.007702:0.007173:0.007914:0.004563:0.007150:0.003540:0.008032:0.005903:0.002352:0.008032:0.003986:0.004198:0.006961:0.003257:0.004210:0.010807:0.008032:0.003540:0.008032:0.007173:0.007644:0.003986:0.003540:0.008032:0.004198:0.006950:0.008702:0.003257:0.004198:0.011289:0.008032:0.004563:0.002352:0.004210:0.009560:0.003257:0.004198:0.006950:0.007702:0.004563:0.002352:0.003986:0.008032:0.007173:0.007702:0.007173:0.003986:0.004198:0.007702:0.003257:0.003257
et al:@0.855053:0.245749:0.881264:0.245749:0.881264:0.233473:0.855053:0.233473:0.007644:0.003986:0.004198:0.008032:0.002352
. Acute :@0.881264:0.245749:0.927078:0.245749:0.927078:0.233473:0.881264:0.233473:0.003257:0.004210:0.008702:0.007608:0.007150:0.003986:0.007644:0.003257
respiratory illness  in patients with COpD and the effectiveness of :@0.544256:0.256650:0.927066:0.256650:0.927066:0.244375:0.544256:0.244375:0.003540:0.007644:0.004563:0.008020:0.002352:0.003540:0.008032:0.003986:0.007702:0.003540:0.006303:0.005233:0.002352:0.002352:0.002352:0.007173:0.007644:0.004563:0.004563:0.003257:0.001987:0.002352:0.007173:0.005233:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.005233:0.009772:0.002352:0.003986:0.007173:0.005233:0.009560:0.010219:0.006961:0.008749:0.005233:0.008032:0.007173:0.008055:0.005233:0.003986:0.007173:0.007644:0.005233:0.007644:0.003692:0.003692:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.007173:0.007644:0.004563:0.004563:0.005233:0.007702:0.003692:0.003257
influenza vaccination.* :@0.544256:0.267552:0.678299:0.267552:0.678299:0.255276:0.544256:0.255276:0.002352:0.007173:0.002852:0.002852:0.007150:0.007644:0.007173:0.004998:0.008032:0.003775:0.006515:0.008032:0.007608:0.007608:0.002352:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.004998:0.003257
Chest:@0.678805:0.267552:0.711731:0.267552:0.711731:0.255276:0.678805:0.255276:0.009560:0.007173:0.007644:0.004563:0.003986
 [Internet]. 2004;125(6):2011-20. Avail-:@0.711731:0.267552:0.923809:0.267552:0.923809:0.255276:0.711731:0.255276:0.003775:0.004127:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.007632:0.003986:0.004127:0.003257:0.003775:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.003810:0.008702:0.006515:0.008032:0.002352:0.002352:0.003904
able from: http://dx.doi.org/10.1378/chest.125.6.2011:@0.544256:0.278453:0.845704:0.278453:0.845704:0.266178:0.544256:0.266178:0.008032:0.008020:0.002352:0.007644:0.003257:0.003692:0.003540:0.007702:0.011030:0.003257:0.003257:0.007173:0.003986:0.003986:0.008020:0.003257:0.005139:0.005139:0.008055:0.005644:0.003257:0.008055:0.007702:0.002352:0.003257:0.007702:0.003540:0.007914:0.005139:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.005139:0.007608:0.007173:0.007644:0.004563:0.003986:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515
10.   Gadsby NJ, Russell CD, Mchugh Mp, Mark H, :@0.519056:0.289355:0.800701:0.289355:0.800701:0.277079:0.519056:0.277079:0.006515:0.006515:0.003257:0.003257:0.003257:0.002399:0.010254:0.008032:0.008055:0.004563:0.008020:0.006303:0.003528:0.008702:0.005668:0.003257:0.003504:0.007138:0.007150:0.004563:0.004563:0.007644:0.002352:0.002352:0.003516:0.009560:0.008749:0.003257:0.003516:0.010807:0.007608:0.007173:0.007150:0.007914:0.007173:0.003504:0.010807:0.006961:0.003257:0.003504:0.010807:0.008032:0.003540:0.005903:0.003516:0.008032:0.003257:0.003257
et al:@0.800960:0.289355:0.826489:0.289355:0.826489:0.277079:0.800960:0.277079:0.007644:0.003986:0.003516:0.008032:0.002352
. Comprehensive :@0.826489:0.289355:0.927078:0.289355:0.927078:0.277079:0.826489:0.277079:0.003257:0.003516:0.009560:0.007702:0.011030:0.008020:0.003540:0.007644:0.007173:0.007644:0.007173:0.004563:0.002352:0.006515:0.007644:0.003257
molecular testing for respiratory pathogens in community-acquired :@0.544256:0.300256:0.927066:0.300256:0.927066:0.287981:0.544256:0.287981:0.011030:0.007702:0.002352:0.007644:0.007608:0.007150:0.002352:0.008032:0.003540:0.002999:0.003986:0.007644:0.004563:0.003986:0.002352:0.007173:0.007914:0.002999:0.003692:0.007702:0.003540:0.002999:0.003540:0.007644:0.004563:0.008020:0.002352:0.003540:0.008032:0.003986:0.007702:0.003540:0.006303:0.002999:0.008020:0.008032:0.003986:0.007173:0.007702:0.007914:0.007644:0.007173:0.004563:0.002999:0.002352:0.007173:0.003010:0.007608:0.007702:0.011030:0.011030:0.007150:0.007173:0.002352:0.003986:0.006303:0.003904:0.008032:0.007608:0.008020:0.007150:0.002352:0.003540:0.007644:0.008055:0.003257
pneumonia. :@0.544256:0.311158:0.617045:0.311158:0.617045:0.298882:0.544256:0.298882:0.008020:0.007173:0.007644:0.007150:0.011030:0.007702:0.007173:0.002352:0.008032:0.003257:0.003257
Clin Infect Dis:@0.617034:0.311158:0.693410:0.311158:0.693410:0.298882:0.617034:0.298882:0.009560:0.002352:0.002352:0.007173:0.003257:0.002658:0.007173:0.003692:0.007644:0.007608:0.003986:0.003257:0.008749:0.002352:0.004563
. 2016;62(7)):817-23. :@0.693410:0.311158:0.808051:0.311158:0.808051:0.298882:0.693410:0.298882:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.003257
11.   Alfageme I, Vazquez R, Reyes N, Mun J. Clinical efficacy of anti-:@0.519056:0.322059:0.923832:0.322059:0.923832:0.309784:0.519056:0.309784:0.006515:0.006515:0.003257:0.003257:0.003257:0.002399:0.008702:0.002352:0.003692:0.008032:0.007914:0.007644:0.011030:0.007644:0.004774:0.002658:0.003257:0.004786:0.008255:0.008032:0.004998:0.008020:0.007150:0.007644:0.004998:0.004774:0.007138:0.003257:0.004786:0.007138:0.007644:0.006303:0.007644:0.004563:0.004786:0.008702:0.003257:0.004786:0.010807:0.007150:0.007173:0.004786:0.005668:0.003257:0.004786:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.004786:0.007644:0.003692:0.002863:0.002863:0.007608:0.008032:0.007608:0.006303:0.004786:0.007702:0.003692:0.004786:0.008032:0.007173:0.003986:0.002352:0.003904
pneumococcal vaccination in patients with COpD.:@0.544256:0.332961:0.844305:0.332961:0.844305:0.320685:0.544256:0.320685:0.008020:0.007173:0.007644:0.007150:0.011030:0.007702:0.007608:0.007702:0.007608:0.007608:0.008032:0.002352:0.004915:0.006515:0.008032:0.007608:0.007608:0.002352:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.004915:0.002352:0.007173:0.004915:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.004915:0.009772:0.002352:0.003986:0.007173:0.004915:0.009560:0.010219:0.006961:0.008749:0.003257
 Thorax.:@0.844305:0.332961:0.889578:0.332961:0.889578:0.320685:0.844305:0.320685:0.004915:0.005009:0.007173:0.007702:0.003540:0.008032:0.005644:0.003257
 2006. :@0.889578:0.332961:0.927066:0.332961:0.927066:0.320685:0.889578:0.320685:0.004915:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
2006;61:189-95. :@0.544256:0.343862:0.632850:0.343862:0.632850:0.331587:0.544256:0.331587:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.003257
12.   Van Werkhoven CH, Van Deursen AMM, sanders EAM, :@0.519056:0.354764:0.862355:0.354764:0.862355:0.342488:0.519056:0.342488:0.006515:0.006515:0.003257:0.003257:0.003257:0.002399:0.008255:0.008032:0.007173:0.004080:0.011289:0.007644:0.003540:0.005903:0.007173:0.007702:0.006515:0.007632:0.007173:0.004080:0.009560:0.008032:0.003257:0.004080:0.008255:0.008032:0.007173:0.004080:0.008749:0.007644:0.007150:0.003540:0.004563:0.007644:0.007173:0.004080:0.008702:0.010807:0.010807:0.003257:0.004057:0.005856:0.008032:0.007173:0.008055:0.007644:0.003540:0.004563:0.004080:0.006303:0.008702:0.010807:0.003257:0.003257
et al:@0.863166:0.354764:0.889249:0.354764:0.889249:0.342488:0.863166:0.342488:0.007644:0.003986:0.004069:0.008032:0.002352
. poly-:@0.889249:0.354764:0.923809:0.354764:0.923809:0.342488:0.889249:0.342488:0.003257:0.004080:0.006961:0.007702:0.002352:0.006303:0.003904
saccharide conjugate vaccine against pneumococcal pneumo-:@0.544256:0.365665:0.923832:0.365665:0.923832:0.353390:0.544256:0.353390:0.004563:0.008032:0.007608:0.007608:0.007173:0.008032:0.003540:0.002352:0.008055:0.007644:0.004833:0.007608:0.007702:0.007173:0.002387:0.007150:0.007914:0.008032:0.003986:0.007644:0.004821:0.006515:0.008032:0.007608:0.007608:0.002352:0.007173:0.007644:0.004833:0.008032:0.007914:0.008032:0.002352:0.007173:0.004563:0.003986:0.004833:0.008020:0.007173:0.007644:0.007150:0.011030:0.007702:0.007608:0.007702:0.007608:0.007608:0.008032:0.002352:0.004821:0.008020:0.007173:0.007644:0.007150:0.011030:0.007702:0.003904
nia in adults. :@0.544256:0.376566:0.618504:0.376566:0.618504:0.364291:0.544256:0.364291:0.007173:0.002352:0.008032:0.003257:0.002352:0.007173:0.003257:0.008032:0.008055:0.007150:0.002352:0.003986:0.004563:0.003257:0.003257
NEJM:@0.618504:0.376566:0.649983:0.376566:0.649983:0.364291:0.618504:0.364291:0.008702:0.006303:0.005668:0.010807
. 2015;372;12:1114-25. :@0.649983:0.376566:0.774408:0.376566:0.774408:0.364291:0.649983:0.364291:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.003257
13.   poole  p, Chong J CC. Mucolytic agents for chronic bronchitis or :@0.519056:0.387468:0.927090:0.387468:0.927090:0.375193:0.519056:0.375193:0.006515:0.006515:0.003257:0.003257:0.003257:0.002399:0.006961:0.007702:0.007702:0.002352:0.007644:0.003257:0.001787:0.006961:0.003257:0.005045:0.009560:0.007173:0.007702:0.007173:0.007914:0.005045:0.005668:0.005045:0.009560:0.009560:0.003257:0.005045:0.010807:0.007150:0.007608:0.007702:0.002352:0.006303:0.003986:0.002352:0.007608:0.005045:0.008032:0.007914:0.007644:0.007173:0.003986:0.004563:0.005045:0.003692:0.007702:0.003540:0.005045:0.007608:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.005045:0.008020:0.003540:0.007702:0.007173:0.007608:0.007173:0.002352:0.003986:0.002352:0.004563:0.005045:0.007702:0.003540:0.003257
chronic obstructive pulmonary disease. :@0.544256:0.398369:0.770915:0.398369:0.770915:0.386094:0.544256:0.386094:0.007608:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.003257:0.007702:0.008020:0.004563:0.003986:0.003540:0.007150:0.007608:0.003986:0.002352:0.006515:0.007644:0.003257:0.008020:0.007150:0.002352:0.011030:0.007702:0.007173:0.008032:0.003540:0.006303:0.003257:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
Cochrane:@0.770903:0.398369:0.829335:0.398369:0.829335:0.386094:0.770903:0.386094:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644
. 2015. :@0.829323:0.398369:0.868411:0.398369:0.868411:0.386094:0.829323:0.386094:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
14.   Herath sC, Normansell R, Maisey s. preventative antibiotic therapy :@0.519056:0.409271:0.927090:0.409271:0.927090:0.396995:0.519056:0.396995:0.006515:0.006515:0.003257:0.003257:0.003257:0.002399:0.008032:0.007644:0.003540:0.008032:0.003986:0.007173:0.003739:0.005856:0.009560:0.003257:0.003739:0.008702:0.007702:0.003540:0.011030:0.008032:0.007173:0.004563:0.007644:0.002352:0.002352:0.003739:0.007138:0.003257:0.003739:0.010807:0.008032:0.002352:0.004563:0.007644:0.006303:0.003751:0.005856:0.003257:0.003751:0.006961:0.003540:0.007644:0.006515:0.007644:0.007173:0.003986:0.008032:0.003986:0.002352:0.006515:0.007644:0.003739:0.008032:0.007173:0.003986:0.002352:0.008020:0.002352:0.007702:0.003986:0.002352:0.007608:0.003751:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257
for people with COpD. :@0.544256:0.420172:0.675630:0.420172:0.675630:0.407897:0.544256:0.407897:0.003692:0.007702:0.003540:0.003257:0.008020:0.007644:0.007702:0.008020:0.002352:0.007644:0.003257:0.009772:0.002352:0.003986:0.007173:0.003257:0.009560:0.010219:0.006961:0.008749:0.003257:0.003257
Cochrane.:@0.675618:0.420172:0.737307:0.420172:0.737307:0.407897:0.675618:0.407897:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257
 2018. :@0.737295:0.420172:0.773126:0.420172:0.773126:0.407897:0.737295:0.407897:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
15.   Hopkins RJ,  Duan  FF,  Chiles C, :@0.519056:0.431074:0.728029:0.431074:0.728029:0.418798:0.519056:0.418798:0.006515:0.006515:0.003257:0.003257:0.003257:0.002399:0.008032:0.007702:0.008020:0.005903:0.002352:0.007173:0.004563:0.005703:0.007138:0.005668:0.003257:0.003257:0.002434:0.008749:0.007150:0.008032:0.007173:0.003257:0.002434:0.005703:0.005703:0.003257:0.003257:0.002434:0.009560:0.007173:0.002352:0.002352:0.007644:0.004563:0.005703:0.009560:0.003257:0.003257
et  al:@0.730475:0.431074:0.758180:0.431074:0.758180:0.418798:0.730475:0.418798:0.007644:0.003986:0.003257:0.002434:0.008032:0.002352
.  Lung  cancer  risk in COpD. :@0.758180:0.431074:0.927078:0.431074:0.927078:0.418798:0.758180:0.418798:0.003257:0.003257:0.002434:0.005433:0.007150:0.007173:0.007914:0.003257:0.002434:0.007608:0.008032:0.007173:0.007608:0.007644:0.003540:0.003257:0.002434:0.003540:0.002352:0.004563:0.005903:0.005703:0.002352:0.007173:0.005703:0.009560:0.010219:0.006961:0.008749:0.003257:0.003257
2017;14(3):392-402. :@0.544256:0.441975:0.654557:0.441975:0.654557:0.429700:0.544256:0.429700:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257:0.003257
16.   Hurst JR, Vestbo J, Antonio A, :@0.519056:0.452877:0.720315:0.452877:0.720315:0.440601:0.519056:0.440601:0.006515:0.006515:0.003257:0.003257:0.003257:0.002399:0.008032:0.007150:0.003540:0.004563:0.003986:0.004727:0.005668:0.007138:0.003257:0.004727:0.008255:0.007644:0.004563:0.003986:0.008020:0.007702:0.004727:0.005668:0.003257:0.004727:0.008702:0.007173:0.003986:0.007702:0.007173:0.002352:0.007702:0.004715:0.008702:0.003257:0.003257
et al:@0.721785:0.452877:0.748526:0.452877:0.748526:0.440601:0.721785:0.440601:0.007644:0.003986:0.004727:0.008032:0.002352
. Abstract. susceptibility to ex-:@0.748526:0.452877:0.923821:0.452877:0.923821:0.440601:0.748526:0.440601:0.003257:0.004727:0.008702:0.008020:0.004563:0.003986:0.003540:0.008032:0.007608:0.003986:0.003257:0.004727:0.005856:0.007150:0.004563:0.007608:0.007644:0.008020:0.003986:0.002352:0.008020:0.002352:0.002352:0.002352:0.003986:0.006303:0.004739:0.003986:0.007702:0.004727:0.007644:0.005644:0.003904
acerbation  in  chronic  obstructive  pulmonary  disease. :@0.544256:0.463778:0.882734:0.463778:0.882734:0.451503:0.544256:0.451503:0.008032:0.007608:0.007644:0.003540:0.008020:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.006338:0.002352:0.007173:0.003257:0.006338:0.007608:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.003257:0.006338:0.007702:0.008020:0.004563:0.003986:0.003540:0.007150:0.007608:0.003986:0.002352:0.006515:0.007644:0.003257:0.006338:0.008020:0.007150:0.002352:0.011030:0.007702:0.007173:0.008032:0.003540:0.006303:0.003257:0.006338:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
NEJM:@0.889084:0.463778:0.920563:0.463778:0.920563:0.451503:0.889084:0.451503:0.008702:0.006303:0.005668:0.010807
. :@0.920563:0.463778:0.927078:0.463778:0.927078:0.451503:0.920563:0.451503:0.003257:0.003257
2010;362;12:1128-38. :@0.544256:0.474680:0.662166:0.474680:0.662166:0.462404:0.544256:0.462404:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.003257
17.   Miravitlles M, Kruesmann F, Haverstock D, perroncel R. Bronchitis ex-:@0.519056:0.485581:0.923809:0.485581:0.923809:0.473306:0.519056:0.473306:0.006515:0.006515:0.003257:0.003257:0.003257:0.002399:0.010807:0.002352:0.003540:0.008032:0.006515:0.002352:0.003986:0.002352:0.002352:0.007644:0.004563:0.003151:0.010807:0.003257:0.003151:0.006950:0.003540:0.007150:0.007644:0.004563:0.011030:0.008032:0.007173:0.007173:0.003140:0.005703:0.003257:0.003140:0.008032:0.008032:0.006515:0.007644:0.003540:0.004563:0.003986:0.007702:0.007608:0.005903:0.003140:0.008749:0.003257:0.003151:0.006961:0.007644:0.003540:0.003540:0.007702:0.007173:0.007608:0.007644:0.002352:0.003140:0.007138:0.003257:0.003140:0.006750:0.003540:0.007702:0.007173:0.007608:0.007173:0.002352:0.003986:0.002352:0.004563:0.003151:0.007644:0.005644:0.003904
acerbations: A pooled analysis. :@0.544256:0.496483:0.725995:0.496483:0.725995:0.484207:0.544256:0.484207:0.008032:0.007608:0.007644:0.003540:0.008020:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.003257:0.003257:0.008702:0.003257:0.008020:0.007702:0.007702:0.002352:0.007644:0.008055:0.003257:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003257:0.003257
Eur Respir J.:@0.725995:0.496483:0.791682:0.496483:0.791682:0.484207:0.725995:0.484207:0.006303:0.007150:0.003540:0.003257:0.007138:0.007644:0.004563:0.008020:0.002352:0.003540:0.003257:0.005668:0.003257
 2012;39(6):1354-60.:@0.791670:0.496483:0.901972:0.496483:0.901972:0.484207:0.791670:0.484207:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257